⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL97689 | 0.90 | — | — | |
| SCHEMBL8812186 | 0.87 | DNM1 (0.50) | — | |
| SCHEMBL666946 | 0.87 | DNM1 (0.50) | — | |
| SCHEMBL98073 | 0.87 | — | — | |
| SCHEMBL465588 | 0.87 | DNM1 (0.50) | — | |
| SCHEMBL8811124 | 0.87 | DNM1 (0.50) | — | |
| SCHEMBL8812602 | 0.87 | DNM1 (0.50) | — | |
| SCHEMBL186389 | 0.87 | — | — | |
| SCHEMBL381495 | 0.87 | DNM1 (0.50) | — | |
| SCHEMBL1960836 | 0.87 | DNM1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1939 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3929207-B1 | PEPTIDE FTTFTVT FOR USE IN TREATING FIBROSIS | UNIV TEXAS (US) | 2024-07-17 | — | — | EP | claimed |
| EP-4396334-A2 | FORMATE DEHYDROGENASE VARIANTS AND METHODS OF USE | Genomatica, Inc. (US) | 2024-07-10 | — | — | EP | claimed |
| EP-4392054-A1 | DOSAGE REGIME | Zealand Pharma A/S (DK) | 2024-07-03 | — | — | EP | claimed |
| EP-4361173-A2 | LONG-ACTING GIP PEPTIDE ANALOGUES | University of Copenhagen (DK) | 2024-05-01 | — | — | EP | claimed |
| EP-3551651-B1 | ACYLATED GLP-1/GLP-2 DUAL AGONISTS | ZEALAND PHARMA AS (DK) | 2024-03-06 | — | — | EP | claimed |
| WO-2023031380-A9 | DOSAGE REGIME | ZEALAND PHARMA A/S (DK) | 2024-02-22 | — | — | WO | claimed |
| EP-4305173-A1 | RECOMBINANT MICROORGANISMS AND USES THEREFOR | Lanzatech, Inc. (US) | 2024-01-17 | — | — | EP | claimed |
| EP-3630806-B1 | LONG-ACTING GIP PEPTIDE ANALOGUES | THE UNIV OF COPENHAGEN (DK) | 2024-01-10 | — | — | EP | claimed |
| US-20230416330-A1 | Optimized GIP Peptide Analogues | ANTAG THERAPEUTICS APS (DK) | 2023-12-28 | — | — | US | claimed |
| EP-4294424-A1 | COMPOSITION FOR TREATING SHORT BOWEL SYNDROME | Zealand Pharma A/S (DK) | 2023-12-27 | — | — | EP | claimed |
| US-4424230-A | CARBAPENICILLIN ANTIBIOTICS | MERCK & CO., INC. (US) | 1984-01-03 | — | — | US | claimed |
| EP-0089290-A1 | Conjugates of haptenes and muramyl peptides having an immunogenic activity, and compositions containing them | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1983-09-21 | — | — | EP | claimed |
| EP-0015773-B1 | N-(6-((ACYLAMINOACYLAMINO OR AMINOACYLAMINO)PHENYL) 1,2-DIHYDRO-2-OXONICOTINYL)PENICILLIN COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND COMPOSITIONS CONTAINING THEM | WARNER-LAMBERT COMPANY (US) | 1983-07-20 | — | — | EP | claimed |
| EP-0082568-A2 | Retro-inverso analogues of C-terminal penta and hexapeptides of substance P. | ANIC S.p.A. (IT) | 1983-06-29 | — | — | EP | claimed |
| US-4278681-A | N-/6-//ACYLAMINOACYLAMINO OR AMINOACYLAMINO/PHENYL/-1,2-DIHYDRO-2-OXONICOTINYL/PENICILLINS | WARNER-LAMBERT CO. (US) | 1981-07-14 | — | — | US | claimed |
| US-4232030-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1980-11-04 | — | — | US | claimed |
| US-4226870-A | ANTIBIOTICS, BACTERICIDES | MERCK & CO., INC. (US) | 1980-10-07 | — | — | US | claimed |
| US-4186194-A | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1980-01-29 | — | — | US | claimed |
| EP-0001265-A1 | O-, N- and carboxyl derivatives of thienamycin sulfoxide and sulfone, their preparation and pharmaceuticals containing said compounds | MERCK & CO. INC. (US) | 1979-04-04 | — | — | EP | claimed |
| EP-0001264-A1 | Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone and their preparation | MERCK & CO. INC. (US) | 1979-04-04 | — | — | EP | claimed |